Anterior Uveitis

21 registered clinical trials studyying Anterior Uveitis — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and NCT07513623	University of California, San Francisco	Phase 2
Completed	A Phase 2 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis NCT06679153	VivaVision Biotech, Inc	Phase 2
Completed	Variations in Retinal Nerve Fiber Layer Thickness During Uncomplicated Anterior and Intermediate Uveitis NCT02879084	CHU de Quebec-Universite Laval	—
Completed	Ocular Sarcoidosis Open Label Trial of ACTHAR Gel NCT02725177	The Cleveland Clinic	N/A
Completed	Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients NCT02764697	Tampa Bay Uveitis Center, LLC	Phase 4
Completed	Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Non-Infectious Anterior Uv NCT02517619	Eyegate Pharmaceuticals, Inc.	Phase 3
Completed	Aqueous Humor Dynamics and Hypertensive Uveitis NCT02765308	Guy's and St Thomas' NHS Foundation Trust	—
Completed	Topical Administration of 0.15% Ganciclovir Gel for CMV Anterior Uveitis / Endotheliitis NCT01647529	Singapore National Eye Centre	N/A
Completed	Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious NCT01505088	Eyegate Pharmaceuticals, Inc.	Phase 3
Unknown	Clinical Outcomes of Topical Ganciclovir Treatment in Cytomegalovirus Anterior Uveitis NCT01486693	National Taiwan University Hospital	—
Completed	Topical Interferon Gamma for Macular Edema Secondary to Uveitis NCT01376362	National Eye Institute (NEI)	Phase 1 / Phase 2
Unknown	Acute Anterior Uveitis: Psychic Burden and Pain NCT01156285	Hospital Hietzing	—
Completed	PEMF: an Adjunct Therapy for Anterior Uveitis NCT01154010	Massachusetts Eye and Ear Infirmary	N/A
Completed	Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti NCT00876434	National Eye Institute (NEI)	Phase 1
Completed	Exploratory Study on Topical ESBA105 in Acute Anterior Uveitis NCT00823173	ESBATech AG	Phase 2
Unknown	Quality of Life and Visual Function in Uveitis Patients NCT00407316	The New York Eye & Ear Infirmary	—
Terminated	A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis NCT00333996	Allergan	Phase 2 / Phase 3
Completed	Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications NCT00476593	Norwegian University of Science and Technology	N/A
Completed	Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated Uveitis NCT00130637	National Eye Institute (NEI)	Phase 2
Completed	Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis NCT00406887	Sirion Therapeutics, Inc.	Phase 3
Completed	Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis NCT00405496	Sirion Therapeutics, Inc.	Phase 2